Risk factors for metabolic and cardiovascular disease in inpatients with severe mental illness

被引:3
作者
Lavagnino, Luca [1 ]
Gurguis, Christopher
Lane, Scott
机构
[1] Univ Texas HSC Houston, McGovern Med Sch, Houston, TX 77030 USA
关键词
Healthcare disparities; Psychiatric illness; Comorbidities; Excess mortality; MAJOR DEPRESSIVE DISORDER; BIPOLAR DISORDER; EXCESS MORTALITY; SCHIZOPHRENIA; POPULATION; PREVALENCE; PEOPLE; INTERVENTION; METAANALYSIS; CHOLESTEROL;
D O I
10.1016/j.psychres.2021.114148
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Patients with severe mental illness (SMI) have increased burden of somatic illnesses, especially cardiovascular disease. Characterizing the cardiovascular risk profile of patients with SMI is therefore crucial to understanding how to decrease morbidity and mortality in these vulnerable populations. In this observational study, entropy balancing (a form of propensity score matching) was used to compare cardiometabolic health in a sample of the general population from the National Health and Nutrition Examination Survey (NHANES) datasets to inpatients hospitalized in a large, urban, academic psychiatric hospital in Harris County, Texas. Data were analyzed using independent linear regression models for blood pressure, blood glucose, TG:HDL ratio, total cholesterol, and body mass index as outcome variables. Systolic blood pressure (F=34.75, p<0.0001), diastolic blood pressure (F=90.53, p<0.0001), blood glucose (F=12.89, p<0.0001), and the TG:HDL ratio (F=3.16, p<0.0001) were all elevated in the psychiatric inpatient sample vs. the NHANES sample. Contrary to expectations, total cholesterol (F=32.18, p<0.0001) and BMI (F=15.05, p<0.0001) were lower in this sample vs. the NHANES sample. Patients hospitalized with SMI show a cardiometabolic profile which confers greater risk of diabetes- and hypertension-related mortality. Approaches should be developed to target indicators of cardiometabolic health in this population to reduce long-term mortality.
引用
收藏
页数:9
相关论文
共 47 条
  • [1] [Anonymous], 2015, PROPENSITY SCORE ANA
  • [2] Arnett DK, 2019, CIRCULATION, V140, pE563, DOI [10.1161/CIR.0000000000000678, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]
  • [3] Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
    Austin, Peter C.
    [J]. STATISTICS IN MEDICINE, 2009, 28 (25) : 3083 - 3107
  • [4] Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence
    Baller, Julia B.
    McGinty, Emma E.
    Azrin, Susan T.
    Juliano-Bult, Denise
    Daumit, Gail L.
    [J]. BMC PSYCHIATRY, 2015, 15
  • [5] Clinicians' recognition of the metabolic adverse effects of antipsychotic medications
    Buckley, PF
    Miller, DD
    Singer, B
    Arena, J
    Stirewalt, EM
    [J]. SCHIZOPHRENIA RESEARCH, 2005, 79 (2-3) : 281 - 288
  • [6] Overt and Hidden Bias in Large Observational Studies
    Cheng, Yu
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (08) : 759 - 760
  • [7] Sex-specific differences in hypertension and associated cardiovascular disease
    Colafella, Katrina M. Mirabito
    Denton, Kate M.
    [J]. NATURE REVIEWS NEPHROLOGY, 2018, 14 (03) : 185 - 201
  • [8] BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment
    Cooper, Stephen J.
    Reynolds, Gavin P.
    Barnes, T. R. E.
    England, E.
    Haddad, P. M.
    Heald, A.
    Holt, R. I. G.
    Lingford-Hughes, A.
    Osborn, D.
    McGowan, O.
    Patel, M. X.
    Paton, C.
    Reid, P.
    Shiers, D.
    Smith, J.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (08) : 717 - 748
  • [9] Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
    Correll, Christoph U.
    Solmi, Marco
    Veronese, Nicola
    Bortolato, Beatrice
    Rosson, Stella
    Santonastaso, Paolo
    Thapa-Chhetri, Nita
    Fornaro, Michele
    Gallicchio, Davide
    Collantoni, Enrico
    Pigato, Giorgio
    Favaro, Angela
    Monaco, Francesco
    Kohler, Cristiano
    Vancampfort, Davy
    Ward, Philip B.
    Gaughran, Fiona
    Carvalho, Andre F.
    Stubbs, Brendon
    [J]. WORLD PSYCHIATRY, 2017, 16 (02) : 163 - 180
  • [10] Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials
    Correll, Christoph U.
    Sheridan, Eva M.
    DelBello, Melissa P.
    [J]. BIPOLAR DISORDERS, 2010, 12 (02) : 116 - 141